Cannabis Law Report

FEBRUARY 3, 2022

The Smart Event allows registered attendees to research exhibitors and products, access exclusive on-demand content, engage in live discussions and schedule meetings. The online platform will open on March 14 and is accessible to all registered visitors. Flexible Packaging Association (FPA). California Life Sciences.

Packaging 52

Packaging Events Education Supply Chain 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

JULY 4, 2021

Perth-based AusCann Group Holdings Limited told the ASX it had bid successfully for a tender from the Health Department for supply of pre-packaged pharmaceutical products to the Tasmanian Health Service, Ambulance Tasmania and other state government health centres. The agreement involved oral capsules.

Medicine 81

Medicine Access Pharmaceutical Packaging 81

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions. It also serves as a hub supporting Tilray’s clinical research and product development efforts across Europe.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

MARCH 19, 2022

Tilray’s EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis. In Malta, patients may obtain prescriptions for medical cannabis and a medical cannabis card through family doctors. About Tilray Medical .

Oil 52

Oil Packaging Patients Access 52

Cannabis Law Report

FEBRUARY 5, 2022

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JULY 26, 2021

“The passage of this legislation greatly immediately accelerates our strategic vision of bringing our cannabis products to international markets as noted by our first international supply agreement out of Cosechemos while we focus expanding our global distribution platform of traditional consumer packaged goods. ” Columbia Decree.

Supply Chain 111

Supply Chain Seed-To-Sale Food Packaging 111

Cannabis Law Report

AUGUST 30, 2021

This has led to increased production of items like cleaning chemicals, sanitizers, masks, and OTC pharmaceuticals to meet local and international demand. Jamaica benefits from preferential market access to several regions through trade agreements, further strengthening its position as an ideal contract manufacturing location.

Research and Development 105

Research and Development Supply Chain Packaging Food 105

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

APRIL 28, 2022

In 2022, over 300 kg of high-quality cannabis flowers have already been harvested, dried and packaged to date. Production will take place at the EU-GMP certified production facility near Dresden and in accordance with the high quality standards of pharmaceutical manufacturing. DEMECAN’s first harvest for pharmacies in Germany.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

DECEMBER 18, 2019

…MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland. The West Australian reports. Source: [link].

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Miss Marijuana

NOVEMBER 4, 2020

The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Not only does Standard Farms have high standards for its products, but it also cares about accessibility. . Its “dry leaf” product comes in virgin, sustainably-sourced packaging and the Terrapin Whole Flower comes in 1 and 3.5

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

NOVEMBER 23, 2021

The proposed site located at Watton, around 23 kilometres from the heart of Bathurst, would be used to grow medical cannabis in a greenhouse environment, along with processing and packaging activities. Further information on the proposed project can be found here.

Chronic Pain 52

Chronic Pain Epilepsy Environment Pharmaceutical 52

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Law School. Holiday Pay.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

OCTOBER 20, 2021

Over the next two years Epsilon’s manufacturing arm, THC Pharma, will receive bulk imports of dried flower for the packaging and release of Australian GMP dried flower. Cannim’s first HummingBud products released. In September Epsilon announced an exclusive partnership with Canadian The Valens Company.

Packaging 52

Packaging Medicine Pharmaceutical Cultivation 52

Cannabis Law Report

OCTOBER 2, 2021

We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Competitive benefit package includes: Paid Time Off (PTO). Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

OCTOBER 10, 2021

Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. As a senior manager at Cantourage and with us as a team you can develop and shape the pharmaceuticals market in Europe. Customized compensation package.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

JUNE 24, 2021

and RAD – are well recognized across the country and through GWNG we will benefit from speed-to-market in Quebec and consumers will have access to our high quality, fairly priced products.”. “Products across all of our brands – Pura Vida, Purefarma, Premium 5, feelgood., and ArthroCBD. About Great White North Growers Inc.

Extraction 95

Extraction Recreational Pharmaceutical Packaging 95

Cannabis Law Report

JULY 13, 2021

Strategic Deal Highlights: The LEP acquisition is expected to provide numerous strategic and financial benefits that will further EVIO’s goal of becoming a leading manufacturer of CBD consumer packaged goods. CBD market—currently estimated at nearly $6 billion and expected to expand at a compound annual growth rate (CAGR) of 21.2%

Research and Development 105

Research and Development Topical Cannabinoids Therapy 105

Cannabis Law Report

JULY 28, 2021

This agreement will provide access to Evotec’s technology platform to further accelerate the development of OCT461201 towards phase 1 clinical trials aimed at demonstrating its safety and tolerability by utilising its “INDiGO” programme, an integrated drug development process for expediting early drug candidates to the clinical trial stage.

Cannabinoids 105

Cannabinoids Clinical Trials Safety Medicine 105

Cannabis Law Report

JULY 19, 2021

LMC Manna Research is also part of hyperCORE International, which has access to more than 100 award winning research sites across two continents making them the second largest clinical research site organization globally. As a decentralized CRO, Knowde Group can engage and manage clinical trials around the globe.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

SpeedWeed

FEBRUARY 19, 2021

. “The transaction gives HEXO immediate access to the European medical cannabis market through Zenabis’ local partner, with an established facility in the European Union supplying pharmaceutical products to the European market,” according to a press release announcing the move.

Pharmaceutical 52

Pharmaceutical Packaging Cultivation Access 52

Cannabis Law Report

APRIL 26, 2022

Cultivators and brands can use this barcode to upload and access test results and compliance certifications. Because this happens with one label, Lucid Green says this system eliminates the tedious process of affixing new labels to product packaging. For example, some brands use QR codes to give consumers more information.

Supply Chain 52

Supply Chain Retail Strains Indica 52

Cannabis Law Report

MARCH 17, 2022

Cannabis strains are accessible in different formulations. Package Date. On the other side, reliable, honest corporations utilize herbal and pharmaceutical -grade grain alcohol to distill cannabinoids. Forgo commodities from manufactory who are reluctant to deliver the data or use vague labeling on their packages.

CBD 52

CBD Extraction Cannabinoids Strains 52

Cannabis Law Report

JANUARY 24, 2020

Hemp Industry Daily reports…… Another product has been approved for use under Ireland’s Medical Cannabis Access Programme (MCAP). Two products were approved for use last year – High CBD Oil Drops from Aurora and CannEpil, which is produced by ASX-listed MGC Pharmaceuticals. It contains 9.6

Oil 59

Oil Epilepsy Conditions Treatment 59

Corante

MARCH 2, 2020

You’ll want to be able to access the test results via a website link or QR code on the packaging. Pay Attention to Packaging. If the packaging is full of bright colors and looks like something that kids will enjoy, it might not be worth spending your money on. Brands and Companies. Is Organic Better?

Oil 40

Oil CBD Packaging Edibles 40

Veriheal

DECEMBER 30, 2020

It would seem logical that if the DEA were looking to acquire a contract with someone who had access to an incinerator that they would reach out to one of the many paper mills in Arizona. But do any of these really want to take on all the added extra security risk involved with handling 8,000 lbs. of illegal drugs daily?

DEA 52

DEA Pharmaceutical Packaging Business 52

SpeedWeed

APRIL 16, 2021

If they can make medical changes soon, that will be really great, because we’ve been waiting years now for some modernization to the program, and I think that it will be really great for patients to get access sooner and for expanded product capacity. If the doctor thinks you will benefit with medical cannabis, then you can get access to it.

Programs 52

Programs Access Patients Packaging 52

SpeedWeed

APRIL 15, 2021

If they can make medical changes soon, that will be really great, because we’ve been waiting years now for some modernization to the program, and I think that it will be really great for patients to get access sooner and for expanded product capacity. If the doctor thinks you will benefit with medical cannabis, then you can get access to it.

Programs 52

Programs Access Patients Packaging 52

SpeedWeed

APRIL 14, 2021

If they can make medical changes soon, that will be really great, because we’ve been waiting years now for some modernization to the program, and I think that it will be really great for patients to get access sooner and for expanded product capacity. If the doctor thinks you will benefit with medical cannabis, then you can get access to it.

Programs 52

Programs Access Patients Packaging 52

Cannabis Law Report

NOVEMBER 23, 2021

(“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today held its first Annual Meeting of Shareholders as the ‘new’ Tilray, the leading cannabis-lifestyle and consumer packaged goods company with the largest global geographic footprint in the industry.

Research and Development 52

Research and Development Cultivation Pharmaceutical Packaging 52

Cannabis Law Report

SEPTEMBER 14, 2021

This alliance is just the first step in a larger movement to co-create a future where consumers have access to trusted cannabinoid products that fully deliver on their potential to help people live healthier, fuller lives.”. Step five: The OBX and Radicle Science validated product is sent to production. About Open Book Extracts.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JUNE 14, 2019

Anvisa only authorizes the importation of plants in cases of research or for the pharmaceutical industry. The package costs, on average, R $ 2,500. The whole environment can only be accessed by biometrics. In addition, there can be no distributors of marijuana for the pharmaceutical industry.

Medicine 40

Medicine Pharmaceutical Environment Cultivation 40

Otherside Farms

MAY 20, 2020

Besides looking for pricing, certificates of analysis (COAs) should be easily accessible for every product, and raw material. The prices of these tests vary, so expect a price tag of several hundred dollars for a complete testing package. When it comes to packaging, there are so many options out there. Build Your Website.

CBD 52

CBD Packaging Banking Research and Development 52